journal article Open Access May 05, 2025

PHARMACOGENOMICS: TAILORING DRUG THERAPY BASED ON GENETIC INFORMATION

View at Publisher Save 10.71465/mrcis115
Abstract
Pharmacogenomics, the study of how genes affect a person’s response to drugs, is an emerging field in personalized medicine that aims to tailor drug therapies based on genetic information. This field holds the potential to improve drug efficacy, minimize adverse drug reactions (ADRs), and reduce healthcare costs. By understanding an individual’s genetic makeup, pharmacogenomics can help predict how patients will respond to specific medications, leading to more effective and safer treatments. This article explores the principles of pharmacogenomics, its clinical applications, the role of genetic variants in drug metabolism, and the challenges faced in implementing pharmacogenomics in routine clinical practice. Special focus is given to the pharmacogenomic landscape in Pakistan and its future potential in improving healthcare outcomes. The article concludes with a discussion on the ethical, social, and logistical challenges of incorporating pharmacogenomics into healthcare systems worldwidey.
Topics

No keywords indexed for this article. Browse by subject →

Metrics
0
Citations
0
References
Details
Published
May 05, 2025
Vol/Issue
5(5)
Pages
488-496
License
View
Cite This Article
Muhammad Akram, Reema Fayez Tayyem (2025). PHARMACOGENOMICS: TAILORING DRUG THERAPY BASED ON GENETIC INFORMATION. Multidisciplinary Research in Computing Information Systems, 5(5), 488-496. https://doi.org/10.71465/mrcis115